(Q60923336)

1

0 references

Minwei Zhang

2

0 references

Yuanzhi Chen

3

0 references

Limin Zhang

4

0 references

Guosong Wang

5

0 references

Junyu Chen

6

0 references

Siyuan Chen

7

0 references

Zizhen Li

8

0 references

Feixue Wei

9

0 references

Jing Chen

10

0 references

Kunyu Yang

11

0 references

Shuxin Guo

12

0 references

Yujing Wang

13

0 references

Qingbing Zheng

14

0 references

Hai Yu

15

0 references

Wenxin Luo

16

0 references

Jun Zhang

17

0 references

Honglin Chen

18

0 references

Yixin Chen

Phase I clinical trial in cancer patients of a new monoclonal antibody FC-2.15 reacting with tumor proliferating cells

19

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

Theranostics

0 references

volume

9

0 references

issue

1

0 references

page(s)

210-231

0 references

cites work

1 reference

12 December 2020

Tumor detection with 131I-labeled human monoclonal antibody COU-1 in patients with suspected colorectal carcinoma

1 reference

12 December 2020

The changing preference of T and B cells for partners as T-dependent antibody responses develop

1 reference

12 December 2020

Control of early viral and bacterial distribution and disease by natural antibodies

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

Oseltamivir: a review of its use in influenza

1 reference

12 December 2020

Intravenous immunoglobulin for treating sepsis and septic shock

1 reference

12 December 2020

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

1 reference

12 December 2020

The treatment of influenza with antiviral drugs

1 reference

12 December 2020

A novel shape complementarity scoring function for protein‐protein docking

1 reference

12 December 2020

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

1 reference

12 December 2020

RDOCK: Refinement of rigid‐body protein docking predictions

1 reference

12 December 2020

UCSF Chimera--a visualization system for exploratory research and analysis

1 reference

12 December 2020

Influenza-associated hospitalizations in the United States

1 reference

12 December 2020

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

1 reference

12 December 2020

Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.

1 reference

12 December 2020

Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir

1 reference

12 December 2020

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen

1 reference

12 December 2020

High level expression of functional human IgMs in human PER.C6 cells

1 reference

12 December 2020

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

1 reference

12 December 2020

Immunoglobulin-M purification--challenges and perspectives.

1 reference

12 December 2020

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

1 reference

12 December 2020

Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance

1 reference

12 December 2020

Mucosal immunity and nasal influenza vaccination

1 reference

12 December 2020

Highly Conserved Protective Epitopes on Influenza B Viruses

1 reference

12 December 2020

The burden of influenza B: a structured literature review

1 reference

12 December 2020

Human monoclonal antibodies broadly neutralizing against influenza B virus

1 reference

12 December 2020

The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78.

1 reference

12 December 2020

The prospects and challenges of universal vaccines for influenza

1 reference

12 December 2020

Integrative genomic analysis of the human immune response to influenza vaccination

1 reference

12 December 2020

Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice

1 reference

12 December 2020

The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to?

1 reference

12 December 2020

Identification of a highly conserved and surface exposed B-cell epitope on the nucleoprotein of influenza A virus

1 reference

12 December 2020

A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.

1 reference

12 December 2020

Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection.

1 reference

12 December 2020

Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.

1 reference

12 December 2020

Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection

1 reference

12 December 2020

Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination

1 reference

12 December 2020

Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.

1 reference

12 December 2020

Burden of influenza B virus infections in Scotland in 2012/13 and epidemiological investigations between 2000 and 2012.

1 reference

12 December 2020

The contrasting phylodynamics of human influenza B viruses.

1 reference

12 December 2020

Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014.

1 reference

12 December 2020

GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.

1 reference

12 December 2020

Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study

1 reference

12 December 2020

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

1 reference

12 December 2020

Immune history profoundly affects broadly protective B cell responses to influenza.

1 reference

12 December 2020

Epidemiological and Phylogenetic Characteristics of Influenza B Infection in Severe Acute Respiratory Infection Cases in Beijing, 2014 to 2015.

1 reference

12 December 2020

Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics

1 reference

12 December 2020

A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

1 reference

12 December 2020

Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli

1 reference

12 December 2020

Progress of small molecular inhibitors in the development of anti-influenza virus agents

1 reference

12 December 2020

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

1 reference

12 December 2020

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

1 reference

12 December 2020

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region

1 reference

12 December 2020

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.

1 reference

12 December 2020

Structural Basis for the Broad, Antibody-Mediated Neutralization of H5N1 Influenza Virus

1 reference

12 December 2020